IL153364A0 - PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION - Google Patents

PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION

Info

Publication number
IL153364A0
IL153364A0 IL15336401A IL15336401A IL153364A0 IL 153364 A0 IL153364 A0 IL 153364A0 IL 15336401 A IL15336401 A IL 15336401A IL 15336401 A IL15336401 A IL 15336401A IL 153364 A0 IL153364 A0 IL 153364A0
Authority
IL
Israel
Prior art keywords
alanyl
arginyl
preparation
aminophenylacetamide
phenylpentanoyl
Prior art date
Application number
IL15336401A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL153364A0 publication Critical patent/IL153364A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL15336401A 2000-07-22 2001-07-18 PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION IL153364A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017979.6A GB0017979D0 (en) 2000-07-22 2000-07-22 Chemical process
PCT/GB2001/003228 WO2002008247A2 (en) 2000-07-22 2001-07-18 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide

Publications (1)

Publication Number Publication Date
IL153364A0 true IL153364A0 (en) 2003-07-06

Family

ID=9896124

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15336401A IL153364A0 (en) 2000-07-22 2001-07-18 PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION

Country Status (18)

Country Link
US (1) US20040101864A1 (cs)
EP (1) EP1320538A2 (cs)
JP (1) JP2004504405A (cs)
KR (1) KR20030033001A (cs)
CN (1) CN1617881A (cs)
AU (1) AU2001270863A1 (cs)
BR (1) BR0112652A (cs)
CA (1) CA2412787A1 (cs)
CZ (1) CZ2003165A3 (cs)
GB (1) GB0017979D0 (cs)
HU (1) HUP0400485A3 (cs)
IL (1) IL153364A0 (cs)
MX (1) MXPA03000607A (cs)
NO (1) NO20030317L (cs)
NZ (1) NZ523217A (cs)
PL (1) PL365426A1 (cs)
WO (1) WO2002008247A2 (cs)
ZA (1) ZA200210247B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130285D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
US7923577B2 (en) 2009-04-27 2011-04-12 International Flavors & Fragrances Inc. Menthylcarboxamides and their use as cooling agents
JP6084021B2 (ja) * 2012-12-04 2017-02-22 富士通テン株式会社 表示システム、表示装置、表示方法、及び、プログラム
CN111848433B (zh) * 2020-07-14 2023-04-28 安徽中草香料股份有限公司 4-氨基苯基乙酰胺的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1155925A (en) * 1967-02-16 1969-06-25 Miles Lab Synthesis Of Octapeptides
US4152322A (en) * 1978-04-28 1979-05-01 Merck & Co., Inc. Process for selective reduction of nitroarginyl peptides with titanium (iii)
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
BR0112652A (pt) 2003-07-01
MXPA03000607A (es) 2003-05-14
WO2002008247A2 (en) 2002-01-31
AU2001270863A1 (en) 2002-02-05
EP1320538A2 (en) 2003-06-25
JP2004504405A (ja) 2004-02-12
CZ2003165A3 (cs) 2003-04-16
US20040101864A1 (en) 2004-05-27
GB0017979D0 (en) 2000-09-13
NO20030317L (no) 2003-03-14
PL365426A1 (en) 2005-01-10
CN1617881A (zh) 2005-05-18
CA2412787A1 (en) 2002-01-31
WO2002008247A3 (en) 2002-10-17
KR20030033001A (ko) 2003-04-26
ZA200210247B (en) 2003-10-31
HUP0400485A3 (en) 2005-02-28
HUP0400485A2 (hu) 2004-06-28
NZ523217A (en) 2004-07-30
NO20030317D0 (no) 2003-01-21

Similar Documents

Publication Publication Date Title
AU2001241068A1 (en) Indole derivatives, process for preparation of the same and use thereof
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
GB9823871D0 (en) 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
IL159067A0 (en) METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
AU4600200A (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
IL153364A0 (en) PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
EP1617810A4 (en) PROCESS FOR THE PREPARATION AND USE OF 1ALPHA, 24 (S) -DIHYDROXYVITAMINE D2
HUP0100146A3 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
IL147862A0 (en) Process and intermediates for the preparation os isoxazolecaroxamides and analogues
HUP0204111A3 (en) Novel process for the preparation of alpha-(2,4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
HUP0202819A3 (en) Process for the preparation of thiazole derivatives and the new intermediates
EG22846A (en) Process for the preparation of urea
AU2001265969A1 (en) Process for the fermentative preparation of l-threonine
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
HUP9803041A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
AU2001267587A1 (en) Method for the production of n,n'-carbonyldiazoles and azolide salts
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
SI1250320T1 (en) Novel process for the preparation of alpha-(2,4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
EG22758A (en) Process for the preparation of urea
AU1724201A (en) Process for the preparation of fluoxetine hydrochloride